A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy

201570 citationsJournal Articlehybrid Open Access

Authors

April Y. Maa · Emory University

William J. Feuer · University of Miami

C. Quentin Davis · LKC Technologies (United States)

Ensa K. Pillow · Oklahoma City VA Medical Center

Tara D. Brown · Oklahoma City VA Medical Center

Rachel M. Caywood · Oklahoma City VA Medical Center

Joel E. Chasan

Abstract

With a VTDR prevalence similar to that in the U.S., the RETeval device will identify about 75% of the population as not having VTDR with 99% accuracy. The device is simple to use, does not require pupil dilation, and has a short testing time.

Topics & Keywords

Retinal Diseases and Treatments Retinal Imaging and Analysis Glaucoma and retinal disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Diabetes and its Complications

Volume 30, Issue 3, pp. 524-532

DOI: 10.1016/j.jdiacomp.2015.12.005

Field-Weighted Citation Impact: 4.26